Papers

4

Total Citations

143

H-Index

3

About

No biography available yet.

Research Focus

Key Achievements

3
H-Index
4
Papers
143
Total Citations
36
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non–small cell lung cancer
94 citations · 2022
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 40
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Not generated yet